These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26833278)

  • 1. DNA damage and antioxidants in treatment naïve children with obsessive-compulsive disorder.
    Şimşek Ş; Gençoğlan S; Yüksel T
    Psychiatry Res; 2016 Mar; 237():133-7. PubMed ID: 26833278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of possible stress-related biochemical markers to oxidative/antioxidative status in obsessive-compulsive disorder.
    Behl A; Swami G; Sircar SS; Bhatia MS; Banerjee BD
    Neuropsychobiology; 2010; 61(4):210-4. PubMed ID: 20389131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative Stress and DNA Damage in Untreated First-Episode Psychosis in Adolescents.
    Şimşek Ş; Gençoğlan S; Yüksel T; Kaplan İ; Alaca R; Aktaş H
    Neuropsychobiology; 2016; 73(2):92-7. PubMed ID: 27003298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative imbalance in child and adolescent patients with obsessive compulsive disorder.
    Kandemir H; Abuhandan M; Aksoy N; Savik E; Kaya C
    J Psychiatr Res; 2013 Nov; 47(11):1831-4. PubMed ID: 24011862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of oxidative metabolism and oxidative DNA damage in patients with obsessive-compulsive disorder.
    Alici D; Bulbul F; Virit O; Unal A; Altindag A; Alpak G; Alici H; Ermis B; Orkmez M; Taysi S; Savas H
    Psychiatry Clin Neurosci; 2016 Feb; 70(2):109-15. PubMed ID: 26388322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D levels in children and adolescents with obsessive compulsive disorder.
    Yazici KU; Percinel Yazici I; Ustundag B
    Nord J Psychiatry; 2018 Apr; 72(3):173-178. PubMed ID: 29168423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity.
    Scahill L; Riddle MA; McSwiggin-Hardin M; Ort SI; King RA; Goodman WK; Cicchetti D; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 1997 Jun; 36(6):844-52. PubMed ID: 9183141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 8-F2-isoprostane, thioredoxin and thioredoxin reductase levels in children with obsessive-compulsive disorder.
    Bilgiç A; Çolak Sivri R; Kılınç İ
    Nord J Psychiatry; 2018 Oct; 72(7):484-488. PubMed ID: 29927677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder.
    Çolak Sivri R; Bilgiç A; Kılınç İ
    Eur Child Adolesc Psychiatry; 2018 Aug; 27(8):977-984. PubMed ID: 29302747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder.
    Kuloglu M; Atmaca M; Tezcan E; Gecici O; Tunckol H; Ustundag B
    Neuropsychobiology; 2002; 46(1):27-32. PubMed ID: 12207144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbid psychopathology and clinical symptomatology in children and adolescents with obsessive-compulsive disorder.
    Anagnostopoulos DC; Korlou S; Sakellariou K; Kondyli V; Sarafidou J; Tsakanikos E; Giannakopoulos G; Liakopoulou M
    Psychiatriki; 2016; 27(1):27-36. PubMed ID: 27110880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative imbalance in obsessive compulsive disorder patients: a total evaluation of oxidant-antioxidant status.
    Selek S; Herken H; Bulut M; Ceylan MF; Celik H; Savas HA; Erel O
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):487-91. PubMed ID: 18006203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortisol and Brain-Derived Neurotrophic Factor Levels Prior to Treatment in Children With Obsessive-Compulsive Disorder.
    Şimşek Ş; Gençoğlan S; Yüksel T; Kaplan İ; Alaca R
    J Clin Psychiatry; 2016 Jul; 77(7):e855-9. PubMed ID: 27314567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive-compulsive disorder.
    Ljungberg M; Nilsson MKL; Melin K; Jönsson L; Carlsson A; Carlsson Å; Forssell-Aronsson E; Ivarsson T; Carlsson M; Starck G
    Acta Neuropsychiatr; 2017 Jun; 29(3):179-190. PubMed ID: 27772535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convergent and discriminant validity of the Children's Yale-Brown Obsessive Compulsive Scale-Symptom Checklist.
    Gallant J; Storch EA; Merlo LJ; Ricketts ED; Geffken GR; Goodman WK; Murphy TK
    J Anxiety Disord; 2008 Dec; 22(8):1369-76. PubMed ID: 18329843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in obsessive-compulsive disorder patients.
    Kawano A; Tanaka Y; Ishitobi Y; Maruyama Y; Ando T; Inoue A; Okamoto S; Imanaga J; Kanehisa M; Higuma H; Ninomiya T; Tsuru J; Akiyoshi J
    Psychiatry Res; 2013 Aug; 209(1):85-90. PubMed ID: 23266021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interrater reliability and clinical efficacy of Children's Yale-Brown Obsessive-Compulsive Scale in an outpatient setting.
    Yucelen AG; Rodopman-Arman A; Topcuoglu V; Yazgan MY; Fisek G
    Compr Psychiatry; 2006; 47(1):48-53. PubMed ID: 16324902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric evaluation of the Children's Yale-Brown Obsessive-Compulsive Scale.
    Storch EA; Murphy TK; Geffken GR; Soto O; Sajid M; Allen P; Roberti JW; Killiany EM; Goodman WK
    Psychiatry Res; 2004 Nov; 129(1):91-8. PubMed ID: 15572188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Obsessive-Compulsive Symptom (OCS) scale of the Child Behavior Checklist: a comparison between Swedish children with Obsessive-Compulsive Disorder from a specialized unit, regular outpatients and a school sample.
    Ivarsson T; Larsson B
    J Anxiety Disord; 2008 Oct; 22(7):1172-9. PubMed ID: 18280696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum selenium and plasma malondialdehyde levels and antioxidant enzyme activities in patients with obsessive-compulsive disorder.
    Ozdemir E; Cetinkaya S; Ersan S; Kucukosman S; Ersan EE
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):62-5. PubMed ID: 18957313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.